Does Medicaid Pay for GLP-1 Medications? (2026)
Whether Medicaid covers a GLP-1 depends on your specific plan; prior authorization is required, and members who are approved typically pay $0-$10 a month.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Where Each Medication Stands[5]
| Medication | What Medicaid does |
|---|---|
| Wegovy (semaglutide) | Coverage varies dramatically by state, and the direction of travel is the story. KFF's January 2026 update counted 13 fee-for-service Medicaid programs still paying for GLP-1s on an obesity indication, three fewer than the 16 it found in 2025. California Medi-Cal dropped all three of Wegovy, Zepbound and Saxenda from weight-loss coverage effective January 1, 2026, and Pennsylvania Medicaid closed weight-loss GLP-1 coverage to adults 21+ effective January 1, 2026. North Carolina moved the other way, REINSTATING weight-management GLP-1 coverage on December 12, 2025. Watch the CMS BALANCE Model, announced December 23, 2025, which offers participating states $245/month GLP-1 pricing. |
| Ozempic (semaglutide) | Covered in nearly all state Medicaid programs for type 2 diabetes diagnosis. |
| Zepbound (tirzepatide) | Coverage varies by state. A small number of states cover Zepbound for obesity with strict criteria. California excludes as of Jan 1, 2026. |
| Mounjaro (tirzepatide) | Covered in most state Medicaid programs for type 2 diabetes. |
| Copay when it is covered | $0-$10 / month |
What a GLP-1 costs a Medicaid member
At Medicaid's typical copay of $0-$10 a month, a covered year of a GLP-1 costs $0 to $120. That is $4,068 to $4,188 less than a year of Wegovy bought for cash from NovoCare ($4,188), and Zepbound's LillyDirect price of $299 to $449 a month is further above it still.
No compounded seller beats a covered Medicaid fill: the cheapest, Collective at $59/mo, still costs $588 a year more than the top of the Medicaid range, so an approval is worth pursuing.
Medicaid is a government plan, and every manufacturer savings card for Wegovy, Ozempic, Zepbound and Mounjaro excludes government-plan members. Novo Nordisk's Wegovy terms say the exclusion holds even if you pay cash and never bill the plan, so the cash comparison for a Medicaid member is the manufacturer's self-pay price or a compounded seller.
Which state Medicaid programs pay for weight loss
Of the 50 state programs we track, 10 cover a GLP-1 for weight management with prior authorization: Delaware, Kansas, Michigan, Minnesota, Missouri, Mississippi, North Carolina, Tennessee, Virginia and Wisconsin. 6 have dropped that coverage (California, Massachusetts, New Hampshire, Pennsylvania, South Carolina and Utah), 1 is due to end it (Rhode Island), and 33 do not cover it. For type 2 diabetes the picture is different: 50 of the 50 cover a GLP-1.
After a Denial from Medicaid
A Medicaid denial leaves two routes: an appeal, and paying cash. With a prescription, a brand-name GLP-1 is generally an eligible HSA or FSA medical expense[3]. Compounded semaglutide and tirzepatide from licensed 503A pharmacies[4] cost far less than the brand; the cheapest sellers are listed below.
It depends which state you are in: anti-obesity drug coverage under Medicaid is a state decision, and the spread is wide. Some states pay for Wegovy and Zepbound behind a prior authorization. Others keep anti-obesity drugs off the formulary altogether[2][1].
Where to go if Medicaid says no
Sellers that say they work with Medicaid
The 8 cheapest cash-pay compounded GLP-1s
| # | Seller | Monthly price | Score | Visit |
|---|---|---|---|---|
| 1 | Collective Compounded semaglutide | $59/mo | 8.4 | Visit |
| 2 | Boston Medical Group Compounded semaglutide | $66/mo | 5.9 | Visit |
| 3 | OurView Health Compounded semaglutide | $75/mo | 6.6 | Visit |
| 4 | Ivim Health Compounded semaglutide | $75/mo | 6.2 | Visit |
| 5 | Embody Compounded semaglutide | $79/mo | 9.3 | Visit |
| 6 | Lean Meds Compounded semaglutide | $79/mo | 9.3 | Visit |
| 7 | NextMeds Compounded semaglutide | $79/mo | 9.2 | Visit |
| 8 | NuuVim Compounded semaglutide | $79/mo | 7.7 | Visit |
Every seller and price, side by side: compare all sellers.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Prior authorization (PA) · Insurance and regulatory
- Step therapy · Insurance and regulatory
- Off-label use · Insurance and regulatory
- Patient assistance program (PAP) · insurance
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
Sources & methodology — as of September 2026
- 1.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 2.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 3.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
- 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 5.GLP Watchdog insurer coverage index (manually curated formulary data)— GLP Watchdog.